Patents by Inventor Marie-Pierre KAZEK

Marie-Pierre KAZEK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRODUCTION OF FLU VACCINE IN MYCELIOPHTHORA THERMOPHILA
    Publication number: 20230346913
    Abstract: Recombinant expression of influenza virus surface proteins in the fungus Myceliophthora thermophila strain C1 is provided. The recombinant proteins are for use in influenza vaccine compositions.
    Type: Application
    Filed: July 11, 2023
    Publication date: November 2, 2023
    Applicant: DYADIC INTERNATIONAL INC.
    Inventors: Mark EMALFARB, Teunis Cornelis Verwoerd, Mark R. Alfenito, Mark Baer, Isabelle Legastelois, Marie-Pierre Kazek, Marie-Clotilde Bernard, Jean Dubayle, Richard Kensinger
  • Production of flu vaccine in
    Patent number: 11738080
    Abstract: Recombinant expression of influenza virus surface proteins in the fungus Myceliophthora thermophila strain C1 is provided. The recombinant proteins are for use in influenza vaccine compositions.
    Type: Grant
    Filed: August 9, 2018
    Date of Patent: August 29, 2023
    Assignee: DYADIC INTERNATIONAL INC.
    Inventors: Mark Emalfarb, Teunis Cornelis Verwoerd, Mark R. Alfenito, Mark Baer, Isabelle Legastelois, Marie-Pierre Kazek, Marie-Clotilde Bernard, Jean Dubayle, Richard Kensinger
  • MENINGOCOCCAL B RECOMBINANT VACCINE
    Publication number: 20220265805
    Abstract: The present disclosure relates to an immunogenic composition comprising a combination of meningococcal antigens which comprises at least one factor H binding protein (fHBP) A protein, at least one fHBP B protein, at least one Neisseria adhesin A (NadA) protein, and at least one detergent-extracted Outer Membrane Vesicle (dOMV). The meningococcal antigens may be from a Neisseria meningitidis serogroup B. The combination of antigens provided a broad coverage of bacteria strains. Further, the present disclosure relates to the use of the immunogenic composition in methods for eliciting an immune response.
    Type: Application
    Filed: February 18, 2022
    Publication date: August 25, 2022
    Inventors: Nadège ARNAUD-BARBE, Vinod BALHARA, Raffaella IANTOMASI, Marie-Pierre KAZEK-DURET, Jacqueline MCCLUSKEY, Laurence QUEMENEUR, Bachra ROKBI, John SHIVER
  • PRODUCTION OF FLU VACCINE IN MYCELIOPHTHORA THERMOPHILA
    Publication number: 20200215183
    Abstract: Recombinant expression of influenza vims surface proteins in the fungus Myceliophthora thermophila strain Cl is provided. The recombinant proteins are for use in influenza vaccine compositions.
    Type: Application
    Filed: August 9, 2018
    Publication date: July 9, 2020
    Inventors: Mark EMALFARB, Teunis Cornelis VERWOERD, Mark R. ALFENITO, Mark BAER, Isabelle LEGASTELOIS, Marie-Pierre KAZEK, Marie-Clotilde BERNARD, Jean DUBAYLE, Richard KENSINGER